Get a Quote

DEFERASIROX
CAS NO.: 201530-41-8
Chemical Formula: C21H15N3O4
Molecular Weight: 373.3600
DMF&GMP status: Please contact us for more details.
Description:
Deferasirox binds to iron and removes it from the blood stream.Deferasirox is used to treat iron overload caused by blood transfusions in adults and children at least 2 years old.Deferasirox is also used to treat chronic iron overload syndrome caused by a genetic blood disorder in adults and children who are at least 10 years old.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
DEFERASIROXTABLET FOR SUSPENSION; ORAL125MGDEFERASIROXACTAVIS ELIZABETH
DEFERASIROX TABLET FOR SUSPENSION; ORAL 250MG DEFERASIROX ACTAVIS ELIZABETH
DEFERASIROX TABLET FOR SUSPENSION; ORAL 500MG DEFERASIROX ACTAVIS ELIZABETH
DEFERASIROX TABLET FOR SUSPENSION; ORAL 125MG EXJADE NOVARTIS
DEFERASIROX TABLET FOR SUSPENSION; ORAL 250MG EXJADE NOVARTIS
DEFERASIROX TABLET FOR SUSPENSION; ORAL 500MG EXJADE NOVARTIS
DEFERASIROX TABLET; ORAL 180MG JADENU NOVARTIS PHARMS CORP
DEFERASIROX TABLET; ORAL 360MG JADENU NOVARTIS PHARMS CORP
DEFERASIROX TABLET; ORAL 90MG JADENU NOVARTIS PHARMS CORP
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
64655045-Apr-19YY 
6596750 24-Jun-17 Y   U - 735
9283209 21-Nov-34 Y Y
Exclusive Data
Exclusivity Code Exclusivity Expiration